Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Vext Science Inc. C.VEXT

Alternate Symbol(s):  VEXTF

Vext Science, Inc. is a cannabis operator. The Company’s expertise spans from cultivation through to retail operations in markets of Arizona and Ohio. It manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD and Herbal Wellness brands. It has THC concentrates, edibles, and... see more

CSE:VEXT - Post Discussion

Vext Science Inc. > Lot's of M&A in Cannabis stocks this year?
View:
Post by askretka on Dec 18, 2020 7:46am

Lot's of M&A in Cannabis stocks this year?

With a lot of stocks getting hit hard last year and one merger creating the biggest company in the space now. We could see a lot of mergers and acquisitions this year? The licenses and the red tape that the smaller companies have gone through will be quite valuable to some of the bigger companies wanting to grow. Also longer term I think Big pharma will step in to at some point and buy one of the larger well run companies realizing that CBD is a huge medical market that they need ro be in.
Comment by SecondLast on Dec 21, 2020 11:46pm
I agree that there will be a lot of M&A even the smaller companies, like HBOR are getting involved. I don't think pharma would go for a big producer. I think they target an Inmed or Willow who make CBD through biosynthesus or like Cardiol who does it pharmaceutically
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities